You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SBRT

Showing 26 - 50 of 1,041
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial (SBRT + atezolizumab and bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • SBRT + atezolizumab and bevacizumab
  • (no location specified)
Aug 3, 2022

Pancreatic Cancer Trial in Rozzano (SBRT and chemo)

Completed
  • Pancreatic Cancer
  • SBRT and chemotherapy
  • Rozzano, Milan, Italy
    Humanitas Research Hospital
Sep 14, 2022

Liver Metastases, Stereotactic Body Radiation Therapy, MRI-guided Treatment Trial in Madison (SBRT)

Recruiting
  • Liver Metastases
  • +2 more
  • SBRT
  • Madison, Wisconsin
    University of Wisconsin
Sep 13, 2022

Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone Trial in Shanghai (Camrelizumab and fluzoparib with concurrent stereotactic body

Recruiting
  • Sarcoma
  • +2 more
  • Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT)
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University, School of Medici
Oct 3, 2023

Gastric Cancer, GastroEsophageal Cancer Trial in Aurora, Colorado Springs, Highlands Ranch (Pembrolizumab, Olaparib,

Recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Aurora, Colorado
  • +2 more
Jan 4, 2023

Liver Cancer Trial in Kansas City (Stereotactic Body Radiation Treatment)

Not yet recruiting
  • Liver Cancer
  • Stereotactic Body Radiation Treatment
  • Kansas City, Kansas
    University of Kansas Medical Center
Feb 13, 2023

Prostate, Lung, Melanoma and Breast Cancer Patients Following

Recruiting
  • Prostate Cancer
  • +3 more
  • SBRT
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Spinal Metastases Trial in Toronto (Radiotherapy)

Recruiting
  • Spinal Metastases
  • Radiotherapy
  • Toronto, Ontario, Canada
    University Health Network
Jan 8, 2023

Sarcoma, Thoracic Cancer, Abdominal Cancer Trial in Saint Louis (Stereotactic body radiotherapy, Research blood draw)

Active, not recruiting
  • Sarcoma
  • +3 more
  • Stereotactic body radiotherapy
  • Research blood draw
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 17, 2022

Prostate Cancer Trial in France (Metformin, Stereotactic Body Radiation Therapy (SBRT) 30 Gray (Gy), Stereotactic Body Radiation

Recruiting
  • Prostate Cancer
  • Angers, France
  • +7 more
Aug 29, 2022

Ovarian Cancer Recurrent Trial in Sutton, London (Niraparib oral capsule, SBRT)

Not yet recruiting
  • Ovarian Cancer Recurrent
  • Niraparib oral capsule
  • SBRT
  • Sutton, Surrey, United Kingdom
  • +1 more
Aug 10, 2023

Hepatocellular Carcinoma Non-resectable, Portal Vein Tumor Thrombus, Immune Checkpoint Inhibitors Trial in Nanning (Cadonilimab,

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • +2 more
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Sep 13, 2023

Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy

Recruiting
  • Urothelial Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

EGF-R Positive NSCLC, Non Small Cell Lung Cancer, EGFR Exon 19 Deletion Trial in Bogotá (Stereotactic Body Radiation Therapy

Not yet recruiting
  • EGF-R Positive Non-Small Cell Lung Cancer
  • +4 more
  • Stereotactic Body Radiation Therapy SBRT
  • Bogotá, Colombia
    CTIC - Centro de Tratamiento e Investigación Sobre Cáncer Luis C
Aug 16, 2023

Colorectal Cancer, Liver Metastasis Colon Cancer Trial in Edmonton (stereotactic body radiation treatment (SBRT))

Not yet recruiting
  • Colorectal Cancer
  • Liver Metastasis Colon Cancer
  • stereotactic body radiation treatment (SBRT)
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Mar 7, 2023

Solid Tumor, Metastatic Solid Tumor, Solid Carcinoma Trial in New York, Seattle (AZD1390, Stereotactic Body Radiotherapy)

Not yet recruiting
  • Solid Tumor
  • +5 more
  • AZD1390
  • Stereotactic Body Radiotherapy
  • New York, New York
  • +1 more
Jan 12, 2023

Non Small Cell Lung Cancer Trial in Buffalo (SBRT)

Recruiting
  • Non Small Cell Lung Cancer
  • SBRT
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 27, 2022

Tumors, Secondary Malignant Tumor Trial (SBRT + LDRT, SBRT alone)

Not yet recruiting
  • Neoplasms
  • Secondary Malignant Neoplasm
  • SBRT + LDRT
  • SBRT alone
  • (no location specified)
Nov 15, 2022

Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)

Not yet recruiting
  • Oligometastatic Prostate Cancer
  • New York, New York
    Columbia University Irving Medical Center / NewYork-Presbyterian
Jun 14, 2023

NSCLC, Stereotactic Body Radiotherapy, Comprehensive Geriatric Assessment Trial in Denmark (Comprehensive Geriatric Assessment)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Comprehensive Geriatric Assessment
  • Aarhus, Aarhus N, Denmark
  • +3 more
Jun 22, 2023

NSCLC Trial (Anlotinib Hydrochloride, penpulimab, SBRT)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Anlotinib Hydrochloride
  • +2 more
  • (no location specified)
Aug 2, 2022

Advanced Hepatocellular Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Feb 7, 2023

Stage IV NSCLC Trial in Wuhan (SBRT+Osimertinib, Osimertinib 80 MG)

Not yet recruiting
  • Stage IV Non-small Cell Lung Cancer
  • SBRT+Osimertinib
  • Osimertinib 80 MG
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated to Tongji Medical College of Huazhong
Oct 13, 2022

Merkel Cell Carcinoma, Skin Cancer Trial in Tampa, Columbus (Nivolumab, Ipilimumab, Stereotactic Body Radiation Therapy (SBRT))

Active, not recruiting
  • Merkel Cell Carcinoma
  • Skin Cancer
  • Tampa, Florida
  • +1 more
Nov 11, 2022

Unresectable Hepatocellular Carcinoma, Pembrolizumab, Lenvatinib Trial in Taipei City (Lenvatinib/Pembrolizumab plus SBRT

Not yet recruiting
  • Unresectable Hepatocellular Carcinoma
  • +3 more
  • Lenvatinib/Pembrolizumab plus SBRT combinations
  • Taipei City, Taiawn, Taiwan
    National Taiwan University Hospital
Jan 30, 2023